umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A group III steroid solution without antibiotic components: an effective cure for external otitis.
Umeå University, Faculty of Medicine, Clinical Sciences, Otorhinolaryngology.
Umeå University, Faculty of Medicine, Clinical Sciences, Otorhinolaryngology.
2005 (English)In: Journal of Laryngology and Otology, ISSN 0022-2151, Vol. 119, no 5, 342-7 p.Article in journal (Refereed) Published
Abstract [en]

The present study was undertaken to compare the clinical benefits of prescribing ear drops containing 0.05% solution of betamethasone dipropionate (BD), and ear drops containing hydrocortisone with oxytetracycline hydrochloride and polymyxin B (HCPB), for topical treatment of external otitis. Fifty-one patients were enrolled in this open randomized, parallel-group, multicentre study, performed in eight different ENT departments. The patients were randomly assigned to one of the two treatment groups: BD (n = 26) and HCPB (n = 25). Only ENT specialists investigated the patients. Bacterial and fungal cultures were raised on days 1 and 11, using swabbed material from ear canals. Twice daily the patients recorded their symptoms during the acute phase, using special diary cards.BD proved a significantly more effective cure than HCPB during the acute phase of external otitis and afforded a lower relapse frequency during a six-month follow-up period. The patients of the BD group were significantly less troubled by itching (p < 0.01) than those in the HCPB group. On day 11, at the end of the acute phase, growth of bacteria (p = 0.03) and fungi (p < 0.01) was less frequent in the BD group than in the HCPB group. No serious adverse events occurred, and those minor events observed were comparable between the two groups.Our conclusion is that the group III steroid solution, BD, cured the external otitis more effectively than did the HCPB solution, whether infected by bacteria or by fungi. No difference was evident regarding adverse effects. Furthermore, price favours a solution without any antibiotic component. In view of these observations, a group III steroid solution ought to be the preferred remedy for external otitis, whether infected or not.

Place, publisher, year, edition, pages
2005. Vol. 119, no 5, 342-7 p.
Keyword [en]
Administration; Topical, Adult, Aged, Anti-Bacterial Agents/*administration & dosage, Anti-Inflammatory Agents/*administration & dosage, Betamethasone/administration & dosage/adverse effects/*analogs & derivatives, Drug Combinations, Ear Canal/microbiology, Female, Humans, Hydrocortisone/administration & dosage/adverse effects, Male, Middle Aged, Otitis Externa/*drug therapy/microbiology, Oxytetracycline/administration & dosage/adverse effects, Polymyxin B/administration & dosage/adverse effects, Treatment Outcome
Identifiers
URN: urn:nbn:se:umu:diva-7735DOI: 10.1258/0022215053945705PubMedID: 15949095OAI: oai:DiVA.org:umu-7735DiVA: diva2:147406
Available from: 2008-01-11 Created: 2008-01-11 Last updated: 2009-11-11Bibliographically approved
In thesis
1. External otitis and its treatment: is a group III steroid without antibiotics sufficent therapy? Experimental and clinical studies
Open this publication in new window or tab >>External otitis and its treatment: is a group III steroid without antibiotics sufficent therapy? Experimental and clinical studies
2005 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

ABSTRACT

External otitis and its treatment. Is a group III steroid without antibiotics sufficient therapy? – Experimental and clinical studies

Per Emgård, Department of Otorhinolaryngology, University of Umeå and Ystad Hospital, Umeå and Ystad, Sweden

External otitis is one of the most common ear, nose and throat (ENT) diagnoses in out-patient clinics. The clinical course of external otitis includes itching, pain, redness, swelling and effusion of the external auditory canal (EAC) with normal tympanic membrane status. The inflammatory condition is often associated with infection by bacteria, e.g. Pseudomonas aeruginosa, or skin bacteria such as Staphylococcus species. Fungi are present only in a low percentage of cases and if present Candida albicans infection is the most frequent in northern countries such as Sweden and the UK. Topical therapy is recommended in most countries and dominates the therapy in most studies. Topical drugs used are usually a combination of antibiotics and a steroid. However, external otitis is treated with surprisingly many strategies – eleven different ones in Sweden, for example, and 18 in the UK.

The aims of the present studies were to –

-establish an animal model, infected and uninfected, suitable for testing various treatment strategies of external otitis; and

-perform a clinical study in patients to elucidate whether a group III steroid alone is as efficient for treatment of external otitis as is the commonly used topical drug containing a combination of a steroid and antibiotics.

The animal model was established through mechanical irritation of the external ear canal skin of Sprague-Dawley rats. An evaluation scale for characterization of the clinical status of the ear canal was introduced, recording redness, swelling and occurrence of effusion in a standardized way. Specimens of the ear canal skin were analysed by histological techniques. A topical solution of 0.05% bethametasone dipropionate (BD) was compared with a 1% hydrocortisone solution with antibiotics oxytetracycline and polymyxin B added (HCPB), administered in the external otitis model infected or non-infected with bacteria (P. aeruginosa) and a fungus (C. albicans).

The same drugs were tested in a randomized parallel-group multi-centre study in 51 patients. The clinical status of the external otitis patients was evaluated on a similar scale as used in the animal model. Early normalization of the ear canal skin status and frequency of relapses during the 6-month follow-up period were used as end-points of the study.

The studies showed the following:

-An animal model for external otitis, infected or uninfected, could be established.

-A new scale for evaluation of the external ear canal status with regard to redness, swelling and occurrence of effusion was introduced for the animal model as well as for the investigations in patients.

-Treatment with a group III steroid topical solution without antibiotics was superior to treatment with a group I steroid with antibiotics added in achieving resolution of external otitis.

-The effectiveness of the topical drugs in the clinical studies in external otitis patients was similar to that in animal external otitis models.

We conclude that a group III steroid solution cures external otitis more effectively than does a solution containing a group I steroid combined with antibiotics, whether infected by bacteria or by fungi. No difference was evident regarding adverse effects. Furthermore, costs favour a solution without any antibiotic components. In view of these observations a group III steroid solution is preferred for remedy of external otitis in the clinical situation.

Key words: external otitis, external auditory canal (EAC), animal model, treatment, betamethasone, hydrocortisone, antibiotics, human study, Pseudomonas aeruginosa, Candida albicans.

Place, publisher, year, edition, pages
Umeå: Klinisk vetenskap, 2005. 87 p.
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 988
Keyword
Medicine, external otitis, external auditory canal (EAC), animal model, treatment, betamethasone, hydrocortisone, antibiotics, human study, Pseudomonas aeruginosa, Candida albicans., Medicin
National Category
Dermatology and Venereal Diseases
Research subject
Oto-Rhino-Laryngology
Identifiers
urn:nbn:se:umu:diva-607 (URN)91-7305-953-6 (ISBN)
Public defence
2005-10-27, sal b (rosa salen, 9tr), tandläkarhögskolan, tandläkarhögskolan, Umeå, 10:00 (English)
Opponent
Supervisors
Available from: 2005-10-11 Created: 2005-10-11 Last updated: 2009-11-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15949095&dopt=Citation
By organisation
Otorhinolaryngology
In the same journal
Journal of Laryngology and Otology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 37 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf